Senior insider sale
Chief Operating Officer at TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$1.41M
19.69K shares
What this filing means
NEERVANNAN SESHADRI plans to sell 19.69K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $1.41M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/19/2026ACC: 0001959173-26-002514
Officer· Chief Operating Officer
Since Oct 2020
19.69K
Shares to sell
$1.41M
Approx. market value
4.59K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/18/2026
4.59KTotal acquired4.59K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/18/2026 | Restricted Stock Vesting Compensation | 4.59K | — |
| Total | 4.59K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
3.61K
Market value
$248.0K
3/18/2026
—Completed
Units to sell
3.13K
Market value
$216.9K
3/17/2026
—Completed
Units to sell
8.37K
Market value
$641.4K
3/4/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.59K
Market value
$307.5K
3/19/2026
Total
Units
19.69K
Value
$1.41M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/18/2026 | 3.61K | $248.0K | — | Completed |
3/17/2026 | 3.13K | $216.9K | — | Completed |
3/4/2026 | 8.37K | $641.4K | — | Completed |
| Planned — Approximate Date | ||||
3/19/2026 | 4.59K | $307.5K | NASDAQ | Planned |
| Total | 19.69K | $1.41M | ||